Log in to search using one of your social media accounts:


Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA(R) (edaravone) to U.S. Department of Veterans Affairs National Formulary

JERSEY CITY, N.J., Nov. 30, 2017 -- (Healthcare Sales &Marketing Network) -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced today that the U.S. Department of Veterans Affairs (VA) has added RADICAVA® (edaravone) to its National Formulary (VA... Biopharmaceuticals, Neurology, Reimbursement Mitsubishi Tanabe Pharma, RADICAVA, edaravone, amyotrophic lateral sclerosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

More News: ALS | Brain | Marketing | Neurology | Pharmaceuticals